Benzydamine Mouth Spray Suppliers & Bulk Manufacturers
Available Forms: Mouth Spray
Available Strengths: 0.15%
Reference Brands: Difflam Oral Spray(US)
Category:
ENT
Benzydamine mouth spray is a topical anti-inflammatory and analgesic agent that reduces pain, inflammation, and swelling in the mouth and throat. It supports relief from sore throats, mouth ulcers, and gingivitis, promoting oral comfort, faster healing, and improved symptoms, supporting oral health worldwide.
Benzydamine Mouth Spray is available in Mouth Spray
and strengths such as 0.15%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Benzydamine Mouth Spray is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Benzydamine Mouth Spray can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Benzydamine mouth spray, marketed as Difflam or Tantum Verde, is approved in the US and EU as an OTC topical agent for oral inflammation and sore throat relief. Regulatory approval requires dossiers including safety, efficacy, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical safety and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe use, and broad availability, helping patients worldwide manage oral inflammation, ulcers, and sore throat symptoms effectively with regionally compliant, high-quality benzydamine formulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing